Proteins

Olon Opens New Proteins Manufacturing Site in Italy

Olon Biotech, a division of Italian API producer Olon, has inaugurated a new facility for the industrial-scale production of proteins from alternative sources at its site in Settimo, Italy. Olon pegged the investment in the new plant at €70 million.

News

Germany’s Merck Buys Erbi Biosystems

Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The company is based in the US state of Massachusetts.

Whitepaper

ExpreS2ion Biotechnologies and Oxford's Jenner Institute Enter Licensing Agreement

News

Nomad Receives €1.2 Million Grant from Saxony-Anhalt

Topics

Therapeutic Proteins: Strategies to Modulate Their Plasma Half-lives

Topics • Chemistry

Chemical Distribution: Three Attractive Markets

Topics • Chemistry

Sustainability All Along The Value Chain

News

DSM Biologics to Acquire Rhobust Technology from Upfront Chromatography

Top-Feature

INOSIM GmbH

Predictive Simulation in Pharma Production

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Event Sponsorship: Next Generation Batteries and Hydrogen

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.